PRTX

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 8/07/2017
Contact Info
  • 131 Columbia Turnpike
  • Suite 1
  • Florham Park, NJ 07932

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Aug 31, 2017 10-Q
CIK 0001099215
Fiscal Year End 5/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 8731 - Commercial physical research
Incorporated In: DE, USA
Year of Inc. 1999
Employees 2 a/o Aug 23, 2017
Company Officers/Contacts
Arnold P. Kling President
Kirk M. Warshaw CFO
Company Directors
Marco M. Elser
Arnold P. Kling
Kirk M. Warshaw
Company Notes
  • Note=12-04 State of Incorporation New Mexico changed to Delaware
  • Note=3-31-05 company is in the development stage, formed to fully develop and bring to commercial realization certain bioregulator technology to treat human diseases
  • Formerly=Enerdyne Corp. until 1-00
Service Providers
Accounting/Auditing Firm
Liggett & Webb, P.A.
432 Park Avenue South, 10 Floor
New York, NY, 10016
United States

Legal Counsel
Morse, Zelnick, Rose & Lander, LLP
825 3rd Avenue
New York, NY, 10022
United States

Investor Relations Firm
LHA Advisors, Inc.
800 Third Avenue
17th Floor
New York, NY, 10022
United States

PRTX Security Details
Share Structure
Market Value1 $11,507,033 a/o Dec 15, 2017
Authorized Shares 100,000,000 a/o Aug 23, 2017
Outstanding Shares 28,767,582 a/o Oct 11, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 6,152,433 a/o May 31, 2017
Par Value 0.00001
Shareholders
Shareholders of Record 252 a/o Aug 22, 2017
Short Selling Data
Short Interest 1,400 (-7.77%)
Nov 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security